DCM Advisors’s NeoGenomics NEO Stock Holding History

DCM Advisors’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-6,000	Closed	-$289K	–	259
2021 Q1	$289K	Hold	6,000	–	–	0.17%	156
2020 Q4	$323K	Buy	+6,000	New	+$271K	0.19%	135

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

DCM Advisors's NEO Position: Q2 2021 in Review

DCM Advisors sold out of NeoGenomics (NEO) in Q2 2021, closing a stake of 6,000 shares — an estimated $289K sold.

DCM Advisors first reported a position in NEO in Q4 2020 and held it in 2 quarters. The position peaked at $323K in Q4 2020. 311 funds tracked by Wall St. Rank hold NEO as of Q2 2021.

DCM Advisors reported no remaining NeoGenomics position as of Q2 2021 after selling out during the quarter.
DCM Advisors sold 6,000 NeoGenomics shares in Q2 2021, an estimated $289K.
DCM Advisors first reported a position in NeoGenomics in Q4 2020 and held it in 2 quarters.
DCM Advisors's NeoGenomics position peaked at $323K in Q4 2020.
311 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2021.

Based on DCM Advisors's 13F filing for Q2 2021, filed 10 Aug 2021.